Mutation of Elfn1 in mice causes seizures and hyperactivity

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Dolan, Jackie ^a   Mitchell, Kevin J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANIMALS; AXONS; BRAIN; CEREBRAL CORTEX; GENE EXPRESSION; GENE ORDER; GENE TARGETING; GENETIC ASSOCIATION STUDIES; HIPPOCAMPUS; HYPERKINESIS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MICE; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; PROTEIN TRANSPORT; SEIZURES;

EID: 84894286592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080491     Document Type: Article

References (98)

1. Kolodkin AL, Tessier-Lavigne M (2011) Mechanisms and molecules of neuronal wiring: a primer. Cold Spring Harbor perspectives in biology 3.
2. Shen K, Scheiffele P (2010) Genetics and cell biology of building specific synaptic connectivity. Annual review of neuroscience 33: 473-507.
3. de Wit J, Hong W, Luo L, Ghosh A (2011) Role of leucine-rich repeat proteins in the development and function of neural circuits. Annual review of cell and developmental biology 27: 697-729.
4. Nose A, Takeichi M, Goodman CS (1994) Ectopic expression of connectin reveals a repulsive function during growth cone guidance and synapse formation. Neuron 13: 525-539.
5. Nose A, Umeda T, Takeichi M (1997) Neuromuscular target recognition by a homophilic interaction of connectin cell adhesion molecules in Drosophila. Development 124: 1433-1441.
6. Shishido E, Takeichi M, Nose A (1998) Drosophila synapse formation: regulation by transmembrane protein with Leu-rich repeats, CAPRICIOUS. Science 280: 2118-2121.
7. Halfon MS, Hashimoto C, Keshishian H (1995) The Drosophila toll gene functions zygotically and is necessary for proper motoneuron and muscle development. Dev Biol 169: 151-167.
8. Shinza-Kameda M, Takasu E, Sakurai K, Hayashi S, Nose A (2006) Regulation of layer-specific targeting by reciprocal expression of a cell adhesion molecule, capricious. Neuron 49: 205-213.
9. Rose D, Zhu X, Kose H, Hoang B, Cho J, et al. (1997) Toll, a muscle cell surface molecule, locally inhibits synaptic initiation of the RP3 motoneuron growth cone in Drosophila. Development 124: 1561-1571.
10. Kurusu M, Cording A, Taniguchi M, Menon K, Suzuki E, et al. (2008) A screen of cell-surface molecules identifies leucine-rich repeat proteins as key mediators of synaptic target selection. Neuron 59: 972-985.
11. Ko J, Kim S, Chung HS, Kim K, Han K, et al. (2006) SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses. Neuron 50: 233-245.
12. Kim S, Burette A, Chung HS, Kwon SK, Woo J, et al. (2006) NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nat Neurosci 9: 1294-1301.
13. Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, et al. (2006) Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313: 1792-1795.
14. Linhoff MW, Lauren J, Cassidy RM, Dobie FA, Takahashi H, et al. (2009) An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61: 734-749.
15. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM (2010) LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. The Journal of neuroscience : the official journal of the Society for Neuroscience 30: 7495-7506.
16. Kwon SK, Woo J, Kim SY, Kim H, Kim E (2010) Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation. The Journal of biological chemistry 285: 13966-13978.
17. Woo J, Kwon SK, Choi S, Kim S, Lee JR, et al. (2009) Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses. Nature Neuroscience 12: 428-437.
18. Mah W, Ko J, Nam J, Han K, Chung WS, et al. (2010) Selected SALM (synaptic adhesion-like molecule) family proteins regulate synapse formation. The Journal of neuroscience : the official journal of the Society for Neuroscience 30: 5559-5568.
19. DeNardo LA, de Wit J, Otto-Hitt S, Ghosh A (2012) NGL-2 regulates input-specific synapse development in CA1 pyramidal neurons. Neuron 76: 762-775.
20. O'Sullivan ML, de Wit J, Savas JN, Comoletti D, Otto-Hitt S, et al. (2012) FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development. Neuron 73: 903-910.
21. Wills ZP, Mandel-Brehm C, Mardinly AR, McCord AE, Giger RJ, et al. (2012) The nogo receptor family restricts synapse number in the developing hippocampus. Neuron 73: 466-481.
22. Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, et al. (2000) Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 26: 319-323.
23. Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, et al. (2002) Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30: 335-341.
24. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310: 317-320.
25. Majercak J, Ray WJ, Espeseth A, Simon A, Shi XP, et al. (2006) LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Proc Natl Acad Sci U S A 103: 17967-17972.
26. Piton A, Gauthier J, Hamdan FF, Lafreniere RG, Yang Y, et al. (2010) Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry.
27. Seppala EH, Jokinen TS, Fukata M, Fukata Y, Webster MT, et al. (2011) LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS genetics 7: e1002194.
28. Reitz C, Conrad C, Roszkowski K, Rogers RS, Mayeux R (2012) Effect of genetic variation in LRRTM3 on risk of Alzheimer disease. Archives of neurology 69: 894-900.
29. Lincoln S, Allen M, Cox CL, Walker LP, Malphrus K, et al. (2013) LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer's Disease (LOAD). PLoS ONE 8: e64164.
30. Berghuis B, Brilstra EH, Lindhout D, Baulac S, de Haan GJ, et al. (2013) Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1/epitempin gene. Epilepsy & behavior : E&B 28: 41-46.
31. Tekin M, Chioza BA, Matsumoto Y, Diaz-Horta O, Cross HE, et al. (2013) SLITRK6 mutations cause myopia and deafness in humans and mice. The Journal of clinical investigation 123: 2094-2102.
32. Stuart HM, Roberts NA, Burgu B, Daly SB, Urquhart JE, et al. (2013) LRIG2 mutations cause urofacial syndrome. American Journal of Human Genetics 92: 259-264.
33. Zeitz C, Jacobson SG, Hamel CP, Bujakowska K, Neuille M, et al. (2013) Whole-exome sequencing identifies LRIT3 mutations as a cause of autosomal-recessive complete congenital stationary night blindness. American Journal of Human Genetics 92: 67-75.
34. Dolan J, Walshe K, Alsbury S, Hokamp K, O'Keeffe S, et al. (2007) The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics 8: 320.
35. Lauren J, Airaksinen MS, Saarma M, Timmusk T (2003) A novel gene family encoding leucine-rich repeat transmembrane proteins differentially expressed in the nervous system. Genomics 81: 411-421.
36. Aruga J, Mikoshiba K (2003) Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol Cell Neurosci 24: 117-129.
37. Morimura N, Inoue T, Katayama K, Aruga J (2006) Comparative analysis of structure, expression and PSD95-binding capacity of Lrfn, a novel family of neuronal transmembrane proteins. Gene 380: 72-83.
38. Chen Y, Aulia S, Li L, Tang BL (2006) AMIGO and friends: An emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res Brain Res Rev 51: 265-274.
39. Rougon G, Hobert O (2003) New insights into the diversity and function of neuronal immunoglobulin superfamily molecules. Annu Rev Neurosci 26: 207-238.
40. Hendrickx A, Beullens M, Ceulemans H, Den Abt T, Van Eynde A, et al. (2009) Docking motif-guided mapping of the interactome of protein phosphatase-1. Chemistry & biology 16: 365-371.
41. Sylwestrak EL, Ghosh A (2012) Elfn1 regulates target-specific release probability at CA1-interneuron synapses. Science 338: 536-540.
42. Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, et al. (2011) Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learning & memory 18: 534-544.
43. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalography and clinical neurophysiology 32: 281-294.
44. Croll SD, Suri C, Compton DL, Simmons MV, Yancopoulos GD, et al. (1999) Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93: 1491-1506.
45. Lloyd KC (2011) A knockout mouse resource for the biomedical research community. Annals of the New York Academy of Sciences 1245: 24-26.
46. Qin C, Luo M (2009) Neurochemical phenotypes of the afferent and efferent projections of the mouse medial habenula. Neuroscience 161: 827-837.
47. Batten TF, Gamboa-Esteves FO, Saha S (2002) Evidence for peptide co-transmission in retrograde- and anterograde-labelled central nucleus of amygdala neurones projecting to NTS. Autonomic neuroscience : basic & clinical 98: 28-32.
48. Muller JF, Mascagni F, McDonald AJ (2007) Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala. The Journal of comparative neurology 500: 513-529.
49. Sadek AR, Magill PJ, Bolam JP (2007) A single-cell analysis of intrinsic connectivity in the rat globus pallidus. The Journal of neuroscience : the official journal of the Society for Neuroscience 27: 6352-6362.
50. Fallon JH, Riley JN, Sipe JC, Moore RY (1978) The islands of Calleja: organization and connections. The Journal of comparative neurology 181: 375-395.
51. Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69: 628-649.
52. Costall B, Domeney AM, Naylor RJ (1984) Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action. Psychopharmacology 82: 174-180.
53. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, et al. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biological psychiatry 49: 81-96.
54. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, et al. (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America 93: 9235-9240.
55. van den Buuse M, de Jong W (1989) Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. The Journal of pharmacology and experimental therapeutics 248: 1189-1196.
56. Butte NF, Treuth MS, Voigt RG, Llorente AM, Heird WC (1999) Stimulant medications decrease energy expenditure and physical activity in children with attention-deficit/hyperactivity disorder. The Journal of pediatrics 135: 203-207.
57. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, et al. (2005) Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics 115: e749-757.
58. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent models of attention-deficit/hyperactivity disorder. Biological psychiatry 57: 1239-1247.
59. Gainetdinov RR (2010) Strengths and limitations of genetic models of ADHD. Attention deficit and hyperactivity disorders 2: 21-30.
60. van der Kooij MA, Glennon JC (2007) Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neuroscience and biobehavioral reviews 31: 597-618.
61. Lee YA, Goto Y (2011) Neurodevelopmental disruption of cortico-striatal function caused by degeneration of habenula neurons. PLoS ONE 6: e19450.
62. Kobayashi Y, Sano Y, Vannoni E, Goto H, Suzuki H, et al. (2013) Genetic dissection of medial habenula-interpeduncular nucleus pathway function in mice. Frontiers in behavioral neuroscience 7: 17.
63. Mitchell KJ, Pinson KI, Kelly OG, Brennan J, Zupicich J, et al. (2001) Functional analysis of secreted and transmembrane proteins critical to mouse development. Nature genetics 28: 241-249.
64. Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, et al. (2001) Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410: 174-179.
65. Fukata Y, Lovero KL, Iwanaga T, Watanabe A, Yokoi N, et al. (2010) Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proceedings of the National Academy of Sciences of the United States of America 107: 3799-3804.
66. Clarke VR, Collingridge GL, Lauri SE, Taira T (2012) Synaptic kainate receptors in CA1 interneurons gate the threshold of theta-frequency-induced long-term potentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience 32: 18215-18226.
67. Goldberg EM, Coulter DA (2013) Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nature reviews Neuroscience 14: 337-349.
68. Milton JG (2012) Neuronal avalanches, epileptic quakes and other transient forms of neurodynamics. The European journal of neuroscience 36: 2156-2163.
69. Panuccio G, Sanchez G, Levesque M, Salami P, de Curtis M, et al. (2012) On the ictogenic properties of the piriform cortex in vitro. Epilepsia 53: 459-468.
70. He DF, Ma DL, Tang YC, Engel J Jr, Bragin A, et al. (2010) Morphophysiologic characteristics of dorsal subicular network in mice after pilocarpine-induced status epilepticus. Brain pathology 20: 80-95.
71. Lipina TV, Niwa M, Jaaro-Peled H, Fletcher PJ, Seeman P, et al. (2010) Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav 9: 777-789.
72. Rünker AE, O'Tuathaigh C, Dunleavy M, Morris DW, Little GE, et al. (2011) Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology. PLoS ONE 6: e26488.
73. Seeman P (2011) All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther 17: 118-132.
74. van den Buuse M (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 36: 246-270.
75. Meyer U, Feldon J, Schedlowski M, Yee BK (2005) Towards an immunoprecipitated neurodevelopmental animal model of schizophrenia. Neuroscience and biobehavioral reviews 29: 913-947.
76. Lipska BK, Weinberger DR (2002) A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox Res 4: 469-475.
77. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull 35: 549-562.
78. Bianco IH, Wilson SW (2009) The habenular nuclei: a conserved asymmetric relay station in the vertebrate brain. Philosophical transactions of the Royal Society of London Series B, Biological sciences 364: 1005-1020.
79. Hikosaka O (2010) The habenula: from stress evasion to value-based decision-making. Nature reviews Neuroscience 11: 503-513.
80. Nishikawa T, Fage D, Scatton B (1986) Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain research 373: 324-336.
81. Park MR (1987) Monosynaptic inhibitory postsynaptic potentials from lateral habenula recorded in dorsal raphe neurons. Brain research bulletin 19: 581-586.
82. Kim U, Chang SY (2005) Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus. The Journal of comparative neurology 483: 236-250.
83. Aizawa H (2013) Habenula and the asymmetric development of the vertebrate brain. Anatomical science international 88: 1-9.
84. Yamaguchi T, Danjo T, Pastan I, Hikida T, Nakanishi S (2013) Distinct roles of segregated transmission of the septo-habenular pathway in anxiety and fear. Neuron 78: 537-544.
85. Quina LA, Wang S, Ng L, Turner EE (2009) Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development. The Journal of neuroscience : the official journal of the Society for Neuroscience 29: 14309-14322.
86. Kim U (2009) Topographic commissural and descending projections of the habenula in the rat. The Journal of comparative neurology 513: 173-187.
87. Simon P, Dupuis R, Costentin J (1994) Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behavioural brain research 61: 59-64.
88. Lammel S, Tye KM, Warden MR (2013) Progress in understanding mood disorders: optogenetic dissection of neural circuits. Genes, brain, and behavior.
89. Mathuru AS, Jesuthasan S (2013) The medial habenula as a regulator of anxiety in adult zebrafish. Frontiers in neural circuits 7: 99.
90. Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, et al. (2013) Distinct extended amygdala circuits for divergent motivational states. Nature 496: 224-228.
91. Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nature reviews Drug discovery 4: 775-790.
92. Cohen R, Senecky Y, Shuper A, Inbar D, Chodick G, et al. (2013) Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. Journal of child neurology 28: 120-123.
93. Reilly CJ (2011) Attention deficit hyperactivity disorder (ADHD) in childhood epilepsy. Research in developmental disabilities 32: 883-893.
94. Dunn DW, Austin JK, Harezlak J, Ambrosius WT (2003) ADHD and epilepsy in childhood. Developmental medicine and child neurology 45: 50-54.
95. Chou IC, Chang YT, Chin ZN, Muo CH, Sung FC, et al. (2013) Correlation between epilepsy and attention deficit hyperactivity disorder: a population-based cohort study. PLoS ONE 8: e57926.
96. Kaufmann R, Goldberg-Stern H, Shuper A (2009) Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. Journal of child neurology 24: 727-733.
97. Flapper BC, Houwen S, Schoemaker MM (2006) Fine motor skills and effects of methylphenidate in children with attention-deficit-hyperactivity disorder and developmental coordination disorder. Developmental medicine and child neurology 48: 165-169.
98. Mitchell KJ (2011) The genetics of neurodevelopmental disease. Current Opinion in Neurobiology 21: 197-203.